Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Jaypirca is a targeted therapy for CLL and other specific cancers. It is known as a Bruton’s tyrosine kinase inhibitor (BTK inhibitor). BTK is an enzyme that helps certain types of cancer cells grow.

Q: My mother was diagnosed with CLL two years ago. She started chemotherapy. The drug ratuximab is her current chemotherapy drug. She has also developed lymphoma. Approximately six months ago she ...

Blood cancer is a cancer that starts in the bone marrow and affects blood cells. Learn about the early signs of blood cancer ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

Myeloblasts are precursors to specific types of white blood cells that help your body fight infections. Too many myeloblasts may be a sign of a blood cancer like leukemia. Myeloblasts, or blast cells, ...

OHSU researchers found that combining venetoclax with breast cancer drug palbociclib strongly improves AML treatment by ...